Burn-induced Heart Failure: Lipopolysaccharide Binding Protein Improves Burn and Endotoxin-Induced Cardiac Contractility Deficits
Background Burn injury is frequently complicated by bacterial infection. Following burn injury, exposure to endotoxin produces a measurable decrease in cardiomyocyte sarcomere contractile function. Lipopolysaccharide-binding protein (LBP) is an acute phase protein that potentiates the recognition of...
Gespeichert in:
Veröffentlicht in: | The Journal of surgical research 2011-01, Vol.165 (1), p.128-135 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 135 |
---|---|
container_issue | 1 |
container_start_page | 128 |
container_title | The Journal of surgical research |
container_volume | 165 |
creator | Niederbichler, Andreas D., M.D Hoesel, Laszlo M., M.D Ipaktchi, Kyros, M.D Olivarez, Leovigildo, B.S.N Erdmann, Martin, M.D Vogt, Peter M., M.D Su, Grace L., M.D Arbabi, Saman, M.D., M.P.H Westfall, Margaret V., Ph.D Wang, Stewart C., M.D., Ph.D Hemmila, Mark R., M.D |
description | Background Burn injury is frequently complicated by bacterial infection. Following burn injury, exposure to endotoxin produces a measurable decrease in cardiomyocyte sarcomere contractile function. Lipopolysaccharide-binding protein (LBP) is an acute phase protein that potentiates the recognition of lipopolysaccharide (LPS) by binding to the lipid A moiety of LPS. In this study, we sought to determine the effect of recombinant rat LBP (rLBP) on cardiomyocyte sarcomere function after burn or sham injury in the presence or absence of bacterial endotoxin. Methods Rats underwent a full-thickness 30% total body surface area scald or sham burn. At 24 h post-injury, cardiomyocytes were isolated, plated at 50,000 cells/well, and incubated with 50 μg/mL LPS and rLBP or chloramphenicol acetyltransferase (BVCat, an irrelevant control protein produced using the same expression system as rLBP) at concentrations by volume of 1%, 5%, 10%, and 30%. Subsets of cardiomyocytes were incubated with 5% rat serum or 30% rLBP and blocking experiments were conducted using an LBP-like synthetic peptide (LBPK95A). In vitro sarcomere function was measured using a variable rate video camera system with length detection software. Results Co-culture of burn and sham injury derived cardiomyocytes with high-dose rLBP in the presence of LPS resulted in a significant reduction to the functional impairment observed in peak sarcomere shortening following exposure to LPS alone. LBP-like peptide LBPK95A at a concentration of 20 μg/mL, in the presence of LPS, abolished the ability of 30% rLBP and 5% rat serum to restore peak sarcomere shortening of cardiomyocytes isolated following burn injury to levels of function exhibited in the absence of endotoxin exposure. Conclusions In the setting of LPS challenge following burn injury, rLBP at high concentrations restores cardiomyocyte sarcomere contractile function in vitro . Rather than potentiating the recognition of LPS by the cellular LPS receptor complex, rLBP at high concentrations likely results in an inhibitory binding effect that minimizes the impact of endotoxin exposure on cardiomyocyte function following thermal injury. |
doi_str_mv | 10.1016/j.jss.2009.06.012 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2891338</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0022480409003400</els_id><sourcerecordid>20085844</sourcerecordid><originalsourceid>FETCH-LOGICAL-c535t-3e47278ae98d1b2c7bf0e36441ce393a1200f9f4486d69352e5ec826130fd3343</originalsourceid><addsrcrecordid>eNp9Uk1vEzEQXSEQDYUfwAX5wnEXf-0XSJXa0NJIkUACzpZjz7azbOyVvYnIkX-OVwnl48DBsqx57834vcmyl4wWjLLqTV_0MRac0ragVUEZf5QtGG3LvKlq8ThbUMp5Lhsqz7JnMfY0vdtaPM3OEqUpGykX2Y-rXXA5OrszYMkt6DCRG43DLsBbssbRj344RG3MvQ5ogVwlKLo78in4CdCR1XYMfg-RzDpEO0uunfWT_44uX51UlzpY1IYsvZuCNhMOOB3Ie-jQ4BSfZ086PUR4cbrPs68311-Wt_n644fV8nKdm1KUUy5A1rxuNLSNZRtu6k1HQVRSMgOiFZqlP3VtJ2VT2aoVJYcSTMMrJmhnhZDiPLs46o67zRasgXmYQY0BtzoclNeo_q44vFd3fq940zIhmiTAjgIm-BgDdA9cRtWch-pVykPNeShaqZRH4rz6s-kD41cACfD6BNDR6KEL2hmMv3GilZyXIuHeHXGQLNojBBUNgkv2YgAzKevxv2Nc_MM2AzpMDb_BAWLvU3jJe8VU5Iqqz_PizHtDW0qFTOcnjF7AAg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Burn-induced Heart Failure: Lipopolysaccharide Binding Protein Improves Burn and Endotoxin-Induced Cardiac Contractility Deficits</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Niederbichler, Andreas D., M.D ; Hoesel, Laszlo M., M.D ; Ipaktchi, Kyros, M.D ; Olivarez, Leovigildo, B.S.N ; Erdmann, Martin, M.D ; Vogt, Peter M., M.D ; Su, Grace L., M.D ; Arbabi, Saman, M.D., M.P.H ; Westfall, Margaret V., Ph.D ; Wang, Stewart C., M.D., Ph.D ; Hemmila, Mark R., M.D</creator><creatorcontrib>Niederbichler, Andreas D., M.D ; Hoesel, Laszlo M., M.D ; Ipaktchi, Kyros, M.D ; Olivarez, Leovigildo, B.S.N ; Erdmann, Martin, M.D ; Vogt, Peter M., M.D ; Su, Grace L., M.D ; Arbabi, Saman, M.D., M.P.H ; Westfall, Margaret V., Ph.D ; Wang, Stewart C., M.D., Ph.D ; Hemmila, Mark R., M.D</creatorcontrib><description>Background Burn injury is frequently complicated by bacterial infection. Following burn injury, exposure to endotoxin produces a measurable decrease in cardiomyocyte sarcomere contractile function. Lipopolysaccharide-binding protein (LBP) is an acute phase protein that potentiates the recognition of lipopolysaccharide (LPS) by binding to the lipid A moiety of LPS. In this study, we sought to determine the effect of recombinant rat LBP (rLBP) on cardiomyocyte sarcomere function after burn or sham injury in the presence or absence of bacterial endotoxin. Methods Rats underwent a full-thickness 30% total body surface area scald or sham burn. At 24 h post-injury, cardiomyocytes were isolated, plated at 50,000 cells/well, and incubated with 50 μg/mL LPS and rLBP or chloramphenicol acetyltransferase (BVCat, an irrelevant control protein produced using the same expression system as rLBP) at concentrations by volume of 1%, 5%, 10%, and 30%. Subsets of cardiomyocytes were incubated with 5% rat serum or 30% rLBP and blocking experiments were conducted using an LBP-like synthetic peptide (LBPK95A). In vitro sarcomere function was measured using a variable rate video camera system with length detection software. Results Co-culture of burn and sham injury derived cardiomyocytes with high-dose rLBP in the presence of LPS resulted in a significant reduction to the functional impairment observed in peak sarcomere shortening following exposure to LPS alone. LBP-like peptide LBPK95A at a concentration of 20 μg/mL, in the presence of LPS, abolished the ability of 30% rLBP and 5% rat serum to restore peak sarcomere shortening of cardiomyocytes isolated following burn injury to levels of function exhibited in the absence of endotoxin exposure. Conclusions In the setting of LPS challenge following burn injury, rLBP at high concentrations restores cardiomyocyte sarcomere contractile function in vitro . Rather than potentiating the recognition of LPS by the cellular LPS receptor complex, rLBP at high concentrations likely results in an inhibitory binding effect that minimizes the impact of endotoxin exposure on cardiomyocyte function following thermal injury.</description><identifier>ISSN: 0022-4804</identifier><identifier>EISSN: 1095-8673</identifier><identifier>DOI: 10.1016/j.jss.2009.06.012</identifier><identifier>PMID: 20085844</identifier><identifier>CODEN: JSGRA2</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acute-Phase Proteins - pharmacology ; Animals ; Apoptosis ; Base Sequence ; Biological and medical sciences ; burn injury ; burn trauma ; Burns ; Burns - complications ; Burns - physiopathology ; cardiac function ; Cardiology. Vascular system ; Carrier Proteins - pharmacology ; Dose-Response Relationship, Drug ; endotoxin ; General aspects ; Heart ; Heart Failure - etiology ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; In Situ Nick-End Labeling ; Langendorff preparation ; lipopolysaccharide-binding protein (LBP) ; Lipopolysaccharides - pharmacology ; Male ; Medical sciences ; Membrane Glycoproteins - pharmacology ; Molecular Sequence Data ; Myocardial Contraction - drug effects ; Myocytes, Cardiac - pathology ; Rats ; Rats, Sprague-Dawley ; Recombinant Proteins - pharmacology ; sarcomere contraction and relaxation ; Sarcomeres - drug effects ; Sarcomeres - physiology ; Surgery ; Traumas. Diseases due to physical agents</subject><ispartof>The Journal of surgical research, 2011-01, Vol.165 (1), p.128-135</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c535t-3e47278ae98d1b2c7bf0e36441ce393a1200f9f4486d69352e5ec826130fd3343</citedby><cites>FETCH-LOGICAL-c535t-3e47278ae98d1b2c7bf0e36441ce393a1200f9f4486d69352e5ec826130fd3343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022480409003400$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23942253$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20085844$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niederbichler, Andreas D., M.D</creatorcontrib><creatorcontrib>Hoesel, Laszlo M., M.D</creatorcontrib><creatorcontrib>Ipaktchi, Kyros, M.D</creatorcontrib><creatorcontrib>Olivarez, Leovigildo, B.S.N</creatorcontrib><creatorcontrib>Erdmann, Martin, M.D</creatorcontrib><creatorcontrib>Vogt, Peter M., M.D</creatorcontrib><creatorcontrib>Su, Grace L., M.D</creatorcontrib><creatorcontrib>Arbabi, Saman, M.D., M.P.H</creatorcontrib><creatorcontrib>Westfall, Margaret V., Ph.D</creatorcontrib><creatorcontrib>Wang, Stewart C., M.D., Ph.D</creatorcontrib><creatorcontrib>Hemmila, Mark R., M.D</creatorcontrib><title>Burn-induced Heart Failure: Lipopolysaccharide Binding Protein Improves Burn and Endotoxin-Induced Cardiac Contractility Deficits</title><title>The Journal of surgical research</title><addtitle>J Surg Res</addtitle><description>Background Burn injury is frequently complicated by bacterial infection. Following burn injury, exposure to endotoxin produces a measurable decrease in cardiomyocyte sarcomere contractile function. Lipopolysaccharide-binding protein (LBP) is an acute phase protein that potentiates the recognition of lipopolysaccharide (LPS) by binding to the lipid A moiety of LPS. In this study, we sought to determine the effect of recombinant rat LBP (rLBP) on cardiomyocyte sarcomere function after burn or sham injury in the presence or absence of bacterial endotoxin. Methods Rats underwent a full-thickness 30% total body surface area scald or sham burn. At 24 h post-injury, cardiomyocytes were isolated, plated at 50,000 cells/well, and incubated with 50 μg/mL LPS and rLBP or chloramphenicol acetyltransferase (BVCat, an irrelevant control protein produced using the same expression system as rLBP) at concentrations by volume of 1%, 5%, 10%, and 30%. Subsets of cardiomyocytes were incubated with 5% rat serum or 30% rLBP and blocking experiments were conducted using an LBP-like synthetic peptide (LBPK95A). In vitro sarcomere function was measured using a variable rate video camera system with length detection software. Results Co-culture of burn and sham injury derived cardiomyocytes with high-dose rLBP in the presence of LPS resulted in a significant reduction to the functional impairment observed in peak sarcomere shortening following exposure to LPS alone. LBP-like peptide LBPK95A at a concentration of 20 μg/mL, in the presence of LPS, abolished the ability of 30% rLBP and 5% rat serum to restore peak sarcomere shortening of cardiomyocytes isolated following burn injury to levels of function exhibited in the absence of endotoxin exposure. Conclusions In the setting of LPS challenge following burn injury, rLBP at high concentrations restores cardiomyocyte sarcomere contractile function in vitro . Rather than potentiating the recognition of LPS by the cellular LPS receptor complex, rLBP at high concentrations likely results in an inhibitory binding effect that minimizes the impact of endotoxin exposure on cardiomyocyte function following thermal injury.</description><subject>Acute-Phase Proteins - pharmacology</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>burn injury</subject><subject>burn trauma</subject><subject>Burns</subject><subject>Burns - complications</subject><subject>Burns - physiopathology</subject><subject>cardiac function</subject><subject>Cardiology. Vascular system</subject><subject>Carrier Proteins - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>endotoxin</subject><subject>General aspects</subject><subject>Heart</subject><subject>Heart Failure - etiology</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>In Situ Nick-End Labeling</subject><subject>Langendorff preparation</subject><subject>lipopolysaccharide-binding protein (LBP)</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - pharmacology</subject><subject>Molecular Sequence Data</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocytes, Cardiac - pathology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Recombinant Proteins - pharmacology</subject><subject>sarcomere contraction and relaxation</subject><subject>Sarcomeres - drug effects</subject><subject>Sarcomeres - physiology</subject><subject>Surgery</subject><subject>Traumas. Diseases due to physical agents</subject><issn>0022-4804</issn><issn>1095-8673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uk1vEzEQXSEQDYUfwAX5wnEXf-0XSJXa0NJIkUACzpZjz7azbOyVvYnIkX-OVwnl48DBsqx57834vcmyl4wWjLLqTV_0MRac0ragVUEZf5QtGG3LvKlq8ThbUMp5Lhsqz7JnMfY0vdtaPM3OEqUpGykX2Y-rXXA5OrszYMkt6DCRG43DLsBbssbRj344RG3MvQ5ogVwlKLo78in4CdCR1XYMfg-RzDpEO0uunfWT_44uX51UlzpY1IYsvZuCNhMOOB3Ie-jQ4BSfZ086PUR4cbrPs68311-Wt_n644fV8nKdm1KUUy5A1rxuNLSNZRtu6k1HQVRSMgOiFZqlP3VtJ2VT2aoVJYcSTMMrJmhnhZDiPLs46o67zRasgXmYQY0BtzoclNeo_q44vFd3fq940zIhmiTAjgIm-BgDdA9cRtWch-pVykPNeShaqZRH4rz6s-kD41cACfD6BNDR6KEL2hmMv3GilZyXIuHeHXGQLNojBBUNgkv2YgAzKevxv2Nc_MM2AzpMDb_BAWLvU3jJe8VU5Iqqz_PizHtDW0qFTOcnjF7AAg</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Niederbichler, Andreas D., M.D</creator><creator>Hoesel, Laszlo M., M.D</creator><creator>Ipaktchi, Kyros, M.D</creator><creator>Olivarez, Leovigildo, B.S.N</creator><creator>Erdmann, Martin, M.D</creator><creator>Vogt, Peter M., M.D</creator><creator>Su, Grace L., M.D</creator><creator>Arbabi, Saman, M.D., M.P.H</creator><creator>Westfall, Margaret V., Ph.D</creator><creator>Wang, Stewart C., M.D., Ph.D</creator><creator>Hemmila, Mark R., M.D</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20110101</creationdate><title>Burn-induced Heart Failure: Lipopolysaccharide Binding Protein Improves Burn and Endotoxin-Induced Cardiac Contractility Deficits</title><author>Niederbichler, Andreas D., M.D ; Hoesel, Laszlo M., M.D ; Ipaktchi, Kyros, M.D ; Olivarez, Leovigildo, B.S.N ; Erdmann, Martin, M.D ; Vogt, Peter M., M.D ; Su, Grace L., M.D ; Arbabi, Saman, M.D., M.P.H ; Westfall, Margaret V., Ph.D ; Wang, Stewart C., M.D., Ph.D ; Hemmila, Mark R., M.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c535t-3e47278ae98d1b2c7bf0e36441ce393a1200f9f4486d69352e5ec826130fd3343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acute-Phase Proteins - pharmacology</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>burn injury</topic><topic>burn trauma</topic><topic>Burns</topic><topic>Burns - complications</topic><topic>Burns - physiopathology</topic><topic>cardiac function</topic><topic>Cardiology. Vascular system</topic><topic>Carrier Proteins - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>endotoxin</topic><topic>General aspects</topic><topic>Heart</topic><topic>Heart Failure - etiology</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>In Situ Nick-End Labeling</topic><topic>Langendorff preparation</topic><topic>lipopolysaccharide-binding protein (LBP)</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - pharmacology</topic><topic>Molecular Sequence Data</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocytes, Cardiac - pathology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Recombinant Proteins - pharmacology</topic><topic>sarcomere contraction and relaxation</topic><topic>Sarcomeres - drug effects</topic><topic>Sarcomeres - physiology</topic><topic>Surgery</topic><topic>Traumas. Diseases due to physical agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niederbichler, Andreas D., M.D</creatorcontrib><creatorcontrib>Hoesel, Laszlo M., M.D</creatorcontrib><creatorcontrib>Ipaktchi, Kyros, M.D</creatorcontrib><creatorcontrib>Olivarez, Leovigildo, B.S.N</creatorcontrib><creatorcontrib>Erdmann, Martin, M.D</creatorcontrib><creatorcontrib>Vogt, Peter M., M.D</creatorcontrib><creatorcontrib>Su, Grace L., M.D</creatorcontrib><creatorcontrib>Arbabi, Saman, M.D., M.P.H</creatorcontrib><creatorcontrib>Westfall, Margaret V., Ph.D</creatorcontrib><creatorcontrib>Wang, Stewart C., M.D., Ph.D</creatorcontrib><creatorcontrib>Hemmila, Mark R., M.D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of surgical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niederbichler, Andreas D., M.D</au><au>Hoesel, Laszlo M., M.D</au><au>Ipaktchi, Kyros, M.D</au><au>Olivarez, Leovigildo, B.S.N</au><au>Erdmann, Martin, M.D</au><au>Vogt, Peter M., M.D</au><au>Su, Grace L., M.D</au><au>Arbabi, Saman, M.D., M.P.H</au><au>Westfall, Margaret V., Ph.D</au><au>Wang, Stewart C., M.D., Ph.D</au><au>Hemmila, Mark R., M.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Burn-induced Heart Failure: Lipopolysaccharide Binding Protein Improves Burn and Endotoxin-Induced Cardiac Contractility Deficits</atitle><jtitle>The Journal of surgical research</jtitle><addtitle>J Surg Res</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>165</volume><issue>1</issue><spage>128</spage><epage>135</epage><pages>128-135</pages><issn>0022-4804</issn><eissn>1095-8673</eissn><coden>JSGRA2</coden><abstract>Background Burn injury is frequently complicated by bacterial infection. Following burn injury, exposure to endotoxin produces a measurable decrease in cardiomyocyte sarcomere contractile function. Lipopolysaccharide-binding protein (LBP) is an acute phase protein that potentiates the recognition of lipopolysaccharide (LPS) by binding to the lipid A moiety of LPS. In this study, we sought to determine the effect of recombinant rat LBP (rLBP) on cardiomyocyte sarcomere function after burn or sham injury in the presence or absence of bacterial endotoxin. Methods Rats underwent a full-thickness 30% total body surface area scald or sham burn. At 24 h post-injury, cardiomyocytes were isolated, plated at 50,000 cells/well, and incubated with 50 μg/mL LPS and rLBP or chloramphenicol acetyltransferase (BVCat, an irrelevant control protein produced using the same expression system as rLBP) at concentrations by volume of 1%, 5%, 10%, and 30%. Subsets of cardiomyocytes were incubated with 5% rat serum or 30% rLBP and blocking experiments were conducted using an LBP-like synthetic peptide (LBPK95A). In vitro sarcomere function was measured using a variable rate video camera system with length detection software. Results Co-culture of burn and sham injury derived cardiomyocytes with high-dose rLBP in the presence of LPS resulted in a significant reduction to the functional impairment observed in peak sarcomere shortening following exposure to LPS alone. LBP-like peptide LBPK95A at a concentration of 20 μg/mL, in the presence of LPS, abolished the ability of 30% rLBP and 5% rat serum to restore peak sarcomere shortening of cardiomyocytes isolated following burn injury to levels of function exhibited in the absence of endotoxin exposure. Conclusions In the setting of LPS challenge following burn injury, rLBP at high concentrations restores cardiomyocyte sarcomere contractile function in vitro . Rather than potentiating the recognition of LPS by the cellular LPS receptor complex, rLBP at high concentrations likely results in an inhibitory binding effect that minimizes the impact of endotoxin exposure on cardiomyocyte function following thermal injury.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>20085844</pmid><doi>10.1016/j.jss.2009.06.012</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-4804 |
ispartof | The Journal of surgical research, 2011-01, Vol.165 (1), p.128-135 |
issn | 0022-4804 1095-8673 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2891338 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Acute-Phase Proteins - pharmacology Animals Apoptosis Base Sequence Biological and medical sciences burn injury burn trauma Burns Burns - complications Burns - physiopathology cardiac function Cardiology. Vascular system Carrier Proteins - pharmacology Dose-Response Relationship, Drug endotoxin General aspects Heart Heart Failure - etiology Heart failure, cardiogenic pulmonary edema, cardiac enlargement In Situ Nick-End Labeling Langendorff preparation lipopolysaccharide-binding protein (LBP) Lipopolysaccharides - pharmacology Male Medical sciences Membrane Glycoproteins - pharmacology Molecular Sequence Data Myocardial Contraction - drug effects Myocytes, Cardiac - pathology Rats Rats, Sprague-Dawley Recombinant Proteins - pharmacology sarcomere contraction and relaxation Sarcomeres - drug effects Sarcomeres - physiology Surgery Traumas. Diseases due to physical agents |
title | Burn-induced Heart Failure: Lipopolysaccharide Binding Protein Improves Burn and Endotoxin-Induced Cardiac Contractility Deficits |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T12%3A52%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Burn-induced%20Heart%20Failure:%20Lipopolysaccharide%20Binding%20Protein%20Improves%20Burn%20and%20Endotoxin-Induced%20Cardiac%20Contractility%20Deficits&rft.jtitle=The%20Journal%20of%20surgical%20research&rft.au=Niederbichler,%20Andreas%20D.,%20M.D&rft.date=2011-01-01&rft.volume=165&rft.issue=1&rft.spage=128&rft.epage=135&rft.pages=128-135&rft.issn=0022-4804&rft.eissn=1095-8673&rft.coden=JSGRA2&rft_id=info:doi/10.1016/j.jss.2009.06.012&rft_dat=%3Cpubmed_cross%3E20085844%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/20085844&rft_els_id=1_s2_0_S0022480409003400&rfr_iscdi=true |